Anne Husebekk
Corporate Officer/Principal en University of Tromso .
Perfil
Anne Husebekk is the founder of Prophylix AS, which was founded in 2008.
She held the title of Chief Operating Officer & Project Developer.
Currently, she is a Professor & Dean-Scientific Affairs at the University of Tromso.
Dr. Husebekk earned a doctorate degree from the University of Tromso.
Cargos activos de Anne Husebekk
| Empresas | Cargo | Inicio |
|---|---|---|
| University of Tromso | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Anne Husebekk.
| Empresas | Cargo | Fin |
|---|---|---|
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Fundador | - |
Formación de Anne Husebekk.
| University of Tromso | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
- Bolsa de valores
- Insiders
- Anne Husebekk
